Insider Transactions in Q2 2023 at Nektar Therapeutics (NKTR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
Roy A Whitfield Director |
SELL
Open market or private sale
|
Direct |
30,000
-12.18%
|
$0
$0.57 P/Share
|
|
May 16
2023
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
9,791
-3.23%
|
$0
$0.72 P/Share
|
|
May 16
2023
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
20,361
-2.12%
|
$0
$0.72 P/Share
|
|
May 16
2023
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,543
-2.84%
|
$0
$0.72 P/Share
|